Physician profile
Bernard Schanzer
NPI 1669442760
$1,494.94
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,166 · 2020: $329.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $386.20 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $278.67 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $210.95 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $90.89 | 2019-2020 | |
| Allergan, INC. | $80.68 | 2019-2020 | |
| Ucb, INC. | $67.70 | 2019-2020 | |
| Lilly USA, LLC | $64.68 | 2019-2020 | |
| Amgen INC. | $62.51 | 2019 | |
| Acadia Pharmaceuticals INC | $48.37 | 2019-2020 | |
| Genzyme Corporation | $44.66 | 2019-2020 | |
| Amneal Pharmaceuticals LLC | $40.19 | 2019 | |
| Emd Serono, INC. | $28.96 | 2019 | |
| Ge Healthcare | $26.16 | 2019 | |
| Neurocrine Biosciences, INC. | $23.25 | 2020 | |
| Acorda Therapeutics, INC | $14.48 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kyowa Kirin, INC. | $14.40 | 2020 | |
| Aprecia Pharmaceuticals, LLC | $12.19 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bernard Schanzer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.